Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518183 | 0.90 | RECQL (0.45) | LMNAKMT2AGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL6523985 | 0.89 | LMNA (0.43) | LMNAKMT2AGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL6520897 | 0.87 | LMNA (0.54) | LMNAKMT2AGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL6522453 | 0.85 | CYP19A1 (0.42) | LMNAKMT2AALDH1A1MEN1MAPT | |
| SCHEMBL6513740 | 0.84 | LMNA (0.45) | LMNAKMT2AGAAALDH1A1MEN1 | |
| SCHEMBL6520633 | 0.82 | SMN1; SMN2 (0.39) | KMT2ASMN1; SMN2ALDH1A1MEN1MAPK1 | |
| SCHEMBL29328685 | 0.81 | LMNA (0.69) | LMNAKMT2AGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL6522380 | 0.80 | KMT2A (0.49) | KMT2ASMN1; SMN2ALDH1A1MEN1PPARG | |
| SCHEMBL6515227 | 0.80 | MEN1 (0.45) | LMNAKMT2AGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL6516174 | 0.80 | LMNA (0.48) | LMNAKMT2AGAASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | LMNA 2459/4885KMT2A 1067/4885GAA 3231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.